Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib (Q34200711)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib |
scientific article |
Statements
1 reference
Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib (English)
1 reference
Pettitt D
1 reference
Goldstein JL
1 reference
Schwartz JS
1 reference
Burke T
1 reference
Maniadakis N
1 reference
1 December 2000
1 reference
1 reference
39 Suppl 2
1 reference
33-42; discussion 57-9
1 reference
Identifiers
1 reference
1 reference